Probable drug-induced liver injury with kedaling tablets : A case report and systematic literature review
Jiabing Wang*
Department of pharmacy, Taizhou Municipal Hospital, Zhejiang Taizhou 318000, China
*Correspondence author
E-mail address: wangjiabing9205@163.com
Abstract
Kedaling tablets is an extract of with Corydalis yanhusuo W.T. Wang and used to coronary heart disease, angina pectoris, myocardial infarction with no previously well documented hepatotoxicity. We report the first case of kedaling tablets-related drug-induced liver injury (DILI), which highlights the need for clinician awareness regarding potential hepatotoxicity of kedaling tablets, particularly among patients with pre-existing liver disease.
Key words:kedaling tablets;drug-induced liver injury;traditional Chinese medicine